Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AAA-604 by Novartis for Pancreatic Cancer: Likelihood of Approval
AAA-604 is under clinical development by Novartis and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase I...
Data Insights
AAA-604 by Novartis for Solid Tumor: Likelihood of Approval
AAA-604 is under clinical development by Novartis and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...